Abstract 936: Targeting TNFR2 for cancer immunotherapy: Ligand blocking depletors versus receptor agonists von Mårtensson, Linda, Cleary, Kirstie, Semmrich, Monika, Kovacek, Mathilda, Holmkvist, Petra, Svensson, Caroline, Demiri, Mimoza, Blidberg, Therese, Thornberg, Ulla-Carin, Pitic, Vincentiu, Dadas, Osman, Lim, Sean H., Beers, Stephen A., Cragg, Mark S., Frendéus, Björn, Teige, Ingrid

Volltext